Page 5 - Haematologica Vol. 109 - July 2024
P. 5
Table of Contents
Volume 109, Issue 7: July 2024
About the Cover
Image taken from the Editorial by Meritxell Alberich-Jorda and Libor Macurek in this issue.
Landmark Paper in Hematology
Editorials
2024 Immunosuppression with posttransplant cyclophosphamide for allogeneic hematopoietic cell transplantation
M. Eapen
https://doi.org/10.3324/haematol.2024.285749
2026 Type I interferons: leukemia’s old foe in the limelight again A. Kumar and S. Swaminathan
https://doi.org/10.3324/haematol.2024.285079
2029 Hematopoietic stem cell fate under the influence of Ser/Thr protein phosphatases M. Alberich-Jorda and L. Macurek
https://doi.org/10.3324/haematol.2024.285040
2032 Indirect treatment comparisons: how to MAIC it right? E. Bachy
https://doi.org/10.3324/haematol.2023.284534
2035 High-risk stays high-risk: Bruton tyrosine kinase inhibitors in B-cell malignancies O. Al-Sawaf
https://doi.org/10.3324/haematol.2024.285029
2038 The clonal hydra: neoantigen-specific T-cell response in germ cell tumors S. Mehra and J. Taylor
https://doi.org/10.3324/haematol.2023.284862
Spotlight Review Article
2041 Hemostasis and endothelial functionality: the double face of coagulation factors C. Olgasi et al.
https://doi.org/10.3324/haematol.2022.282272
Review Articles
2049 Role of minimal residual disease assessment in multiple myeloma R. Szalat et al.
https://doi.org/10.3324/haematol.2023.284662
Haematologica | 109 July 2024
I
